Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Gross

Showing results (151-160 of 244) with videos related to

Pageof 25
Sort By:
Plos One|June 24, 2011
Early mortality and AIDS progression despite high initial antiretroviral therapy adherence and virologic suppression in BotswanaKatherine T Steele, Andrew P Steenhoff, Craig W Newcomb, et al.
AIDS (London, England)|July 7, 2012
Patterns of antiretroviral therapy adherence and impact on HIV RNA among patients in North AmericaBecky L Genberg, Ira B Wilson, David R Bangsberg, et al.
AIDS (London, England)|July 27, 2006
Diagnostic accuracy of CD4 cell count increase for virologic response after initiating highly active antiretroviral therapyGregory P Bisson, Robert Gross, Jordan B Strom, et al.
Drug and Alcohol Dependence|May 15, 2019
Placebo-controlled randomized clinical trial testing the efficacy and safety of varenicline for smokers with HIVRebecca L Ashare, Morgan Thompson, Katrina Serrano, et al.
AIDS (London, England)|April 21, 2012
Antiretroviral therapy interruptions result in loss of protective humoral immunity to neoantigens in HIV-infected individualsLivio Azzoni, Andrea S Foulkes, Cynthia Firnhaber, et al.
AIDS and Behavior|November 11, 2022
The Impact of the COVID-19 Pandemic on Stress, Isolation, Smoking Behaviors, and Motivation to Quit in People with HIV Who SmokePatricia A Cioe, Robert Schnoll, Bettina B Hoeppner, et al.
Journal of General Internal Medicine|June 26, 2007
Adherence to warfarin assessed by electronic pill caps, clinician assessment, and patient reports: results from the IN-RANGE studyCatherine S Parker, Zhen Chen, Maureen Price, et al.
AIDS Research and Therapy|October 17, 2025
Moderate agreement between the spot albumin‒Creatinine ratio (ACR) and urine albumin (UA) among virally suppressed adults living with HIV in botswana: a cross sectional studyMosepele Mosepele, Ponego L Ponatshego, Kesaobaka Molebatsi, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|April 12, 2020
Heme oxygenase-1 promoter (GT) <sub></sub> polymorphism associates with HIV neurocognitive impairmentRolando Garza, Alexander J Gill, Brandon L Bastien, et al.
Archives of Internal Medicine|February 14, 2007
The influence of patient adherence on anticoagulation control with warfarin: results from the International Normalized Ratio Adherence and Genetics (IN-RANGE) StudyStephen E Kimmel, Zhen Chen, Maureen Price, et al.
Pageof 25

Showing results (151-160 of 244) with videos related to

Sort By:
Pageof 25
Plos One|June 24, 2011
Early mortality and AIDS progression despite high initial antiretroviral therapy adherence and virologic suppression in BotswanaKatherine T Steele, Andrew P Steenhoff, Craig W Newcomb, et al.
AIDS (London, England)|July 7, 2012
Patterns of antiretroviral therapy adherence and impact on HIV RNA among patients in North AmericaBecky L Genberg, Ira B Wilson, David R Bangsberg, et al.
AIDS (London, England)|July 27, 2006
Diagnostic accuracy of CD4 cell count increase for virologic response after initiating highly active antiretroviral therapyGregory P Bisson, Robert Gross, Jordan B Strom, et al.
Drug and Alcohol Dependence|May 15, 2019
Placebo-controlled randomized clinical trial testing the efficacy and safety of varenicline for smokers with HIVRebecca L Ashare, Morgan Thompson, Katrina Serrano, et al.
AIDS (London, England)|April 21, 2012
Antiretroviral therapy interruptions result in loss of protective humoral immunity to neoantigens in HIV-infected individualsLivio Azzoni, Andrea S Foulkes, Cynthia Firnhaber, et al.
AIDS and Behavior|November 11, 2022
The Impact of the COVID-19 Pandemic on Stress, Isolation, Smoking Behaviors, and Motivation to Quit in People with HIV Who SmokePatricia A Cioe, Robert Schnoll, Bettina B Hoeppner, et al.
Journal of General Internal Medicine|June 26, 2007
Adherence to warfarin assessed by electronic pill caps, clinician assessment, and patient reports: results from the IN-RANGE studyCatherine S Parker, Zhen Chen, Maureen Price, et al.
AIDS Research and Therapy|October 17, 2025
Moderate agreement between the spot albumin‒Creatinine ratio (ACR) and urine albumin (UA) among virally suppressed adults living with HIV in botswana: a cross sectional studyMosepele Mosepele, Ponego L Ponatshego, Kesaobaka Molebatsi, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|April 12, 2020
Heme oxygenase-1 promoter (GT) <sub></sub> polymorphism associates with HIV neurocognitive impairmentRolando Garza, Alexander J Gill, Brandon L Bastien, et al.
Archives of Internal Medicine|February 14, 2007
The influence of patient adherence on anticoagulation control with warfarin: results from the International Normalized Ratio Adherence and Genetics (IN-RANGE) StudyStephen E Kimmel, Zhen Chen, Maureen Price, et al.
Pageof 25